semaglutide and thyroid medication Assessment of Carcinogenic Risk Safety Profile of GLP1-RA (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review Semaglutide tablets: Availability, efficacy, and

The GLP-1 weight loss field is advancing rapidly, and patients deserve providers who are trained to prescribe these medications safely and effectively

Unlike oral supplements, injections bypass the digestive system entirely, offering faster delivery and greater bioavailability

However, about half of the patients who take these drugs stop within a year because of unwanted side effects

Blackman A, Foster GD, Zammit G et al (2016) Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

19 In the STEP 4 withdrawal trial, patients who stopped at week 20 gained back nearly 7% of their body weight over the next 48 weeks, while those who continued the drug kept losing